E-mail address; yosizumi@nara.kindai.ac.jp Abbreviations: PUFA, polyunsaturated fatty acid; PL, phos pholipids; TG, triacylglycerols; PE, phosphatidylethanolamine; PC, phosphatidylcholine; GLC, gas-liquid chromatography; TLC, thin-layer chromatograohy; PUFAs are designated by the number of carbon atoms and double bonds. "n" indicates the number of carbon atoms from the methyl end of the acyl chain to the nearest double bond. 20 :4 n-6 in cellular phospholipids. Arachidonic acid in cellular phospholipids and its metabolites play impor tant physiological roles in the animal body; e.g., inflam matory response (4-7), signal transduction (8) (9) (10) , regulation of blood pressure (11, 12) , and so on. However, the surplus accumulation of cellular 20:4 n-6 and its metabolites is associated with many inflamma tory diseases. For example, concentrations of 20:4 n-6 metabolites are elevated in skin lesions of patients with psoriasis and atopic dermatitis (13, 14) . If the level of cellular 20:4 n-6 could be decreased in the part of lesion with inflammation by replacement of 20:4 n-6 with other PUFAs, an effective treatment for cutaneous in flammation could likely be established. However, the mechanism by which the cells distinguish between the chemical structure of 20:4 n-6 and other PUFAs is cur rently unclear. urated fatty acids (PUFAs) (Fig. 1) , namely, mead acid (20:3 n-9), dihomo-y-linolenic acid (20:3 n-6), arachi donic acid (20:4 n-6), 11,14,17-cis-eicosatrienoic acid (20:3 n-3), eicosapentaenoic acid (20:5 n-3), and 5,8,11,14-cis-nonadecatetraenoic acid (19:4 n-5), were prepared, and their competitive incorporation into FRSK cells was analyzed by adding two PUFAs simulta neously to the culture medium. The amount of each PUFA incorporated into total cellular lipids and into lipid classes, as well as into phospholipid subclasses of cells, was analyzed by using capillary gas-liquid chro matography.
MATERIALS AND METHODS
Chemicals. Arachidonic acid (20:4 n-6) methyl ester, eicosapentaenoic acid (20:5 n-3) methyl ester, mead acid (20:3 n-9) methyl ester, dihomo-y-linolenic acid (20:3 n-6) methyl ester, and 11,14,17-cis eicosatrienoic acid (20:3 n-3) methyl ester were pur chased from Funakoshi Co. (Tokyo, Japan). 5, 8,11,14 -cis-Nonadecatetraenoic acid (19:4 n-5) methyl ester was purified from a mycelial lipid extracted from Saprolegnia sp. 28YTF-1 grown with n-pentadecanoic acid (15:0) methyl ester (15 
RESULTS

Incorporation of PUFAs and their elongated products into FRSK cells
In repeated preliminary experiments conducted prior to the present study, PUFA methyl esters and the vehicle (ethanol) solutions, at the concentrations used in this study, proved to have no effect on the growth of FRSK cells (data not shown). As shown in Table 1 , when FRSK cells were grown in the delipidated MEM, cellular fatty acid compositions consisted mainly of 16:0, 16:1 n-7, 18:0, and 18:1 n-9. When 20:3 n-9, 20:4 n-6, 20:5 n-3, or 19:4 n-5 was added to the medium, only their 2-carbon elongated product was additionally iden tified from the cells, whereas their desaturated forms were not detected. When 20:3 n-6 and 20:3 n-3 was added to the medium, neither their 2-carbon elongated product nor their desaturated forms were detected from the cells. The amount of PUFAs incorporated into FRSK cells in total (C20-PUFA+its elongated product in the cells) was about 130nmol/protein when C20-PUFAs (20:3 n-9, 20:3 n-6, 20:4 n-6, and 20:5 n-3) were added to the medium, while it was only about 60nmol/protein when 20:3 n-3 was added. When 19:4 n-5, an odd-chain fatty acid, was added, the total acid (Fig.  2b, c) As shown in Fig. 3 , two out of four arachidonic acid analogs (20:3 n-9, 20:4 n-6, 20:5 n-3, and 19:4 n-5), in various combinations, were added to the culture medium in the ratios of 1:0, 0.5:0.5, or 0:1, and the amount of PUFAs incorporated into the total cellular lipid and the lipid classes, PL and TG, of FRSK cells was measured. In the incorporation of PUFAs into the total celluar lipid, when two out of four arachidonic acid analogs were simultaneously added to the medium at the ratio of 0.5:0.5, there were significant differences between each combination in the amount of incorpora tion of PUFAs into the total cellular lipid. 20:4 n-6 and 19:4 n-5 were preferably incorporated into the total cel lular lipid as compared with 20:3 n-9 and 20:5 n-3 (Fig.  2a, b, d, e) . The relative ease of incorporation of arachi donic acid analogs into the total cellular lipid of FRSK cells can be stated as follows 19:4 n-5>20:4 n-6>20:3 The relative ease of incorporation of the eicosatrienoic acids into PE was as follows: 20:3 n-9>20:3 n-6>20:3 n-3, and that into PC was as follows: 20:3 n-6>20:3 n 9>20:3 n-3.
Subsequently, the incorporation of arachidonic acid analogs into PL subclasses, PE and PC, was examined.
As shown in Table 3 In this study, the incorporated PUFA was indicated by the total amount of PUPA and its elongated PUPA in the cells. The keratinocytes are a cell displaying a highly ac tive metabolism 20:4 n-6 to eicosanoids. However, the amounts of eicosanoids in the epidermal cells were at the levels of pmol/mg cellular protein (21, 22) and ex tremely lower than the cellular PUFAs and added PUFAs to the medium (that of nmol/mg cellular protein and nmol/mL). Therefore, we took no account of the amount metabolized to eicosanoids in the present study. 19:4 n-5 has same number and positions of double bond from the carboxyl group and only different double bonds from the methyl end as 20:4 n-6. When two PUFAs were added simultaneously to the medium, 19:4 n-5 most effectively reduced the incorporation of 20:4 n-6 into phospholipids. With regard to incorporation into PE and PC, 19:4 n-5 and 20:4 n-6 were incorpo rated at almost the same levels. These results suggest that 19:4 n-5 is able to decrease the incorporation of 20:4 n-6, the precursor of eicosanoid, into phospho lipids more effectively than other PUFAs. The present study indicates that the ability of fatty acids such as 19:4 n-5 to replace 20:4 n-6 depends to a large extent on the number and position of the double bonds relative to the carboxyl group. Given that arachidonic acid (20:4 n-6) and its metabolites are known to be associ ated with skin inflammation (23, 24) , suppression of their accumulation in epidermis by the exogenous ap plication of other PUFAs may be effective to prevent or reduce skin inflammation. Further studies are neces sary to develop a method by which to control the level of 20:4 n-6 in the phospholipids of keratinocytes.
